Liraglutide Doses Below 3.0 mg Show Real-World Benefit, but Cost Blocks Half of Patients
A Taiwanese post-marketing surveillance study finds that nearly half of patients who failed to reach the approved 3.0 mg liraglutide ...
A Taiwanese post-marketing surveillance study finds that nearly half of patients who failed to reach the approved 3.0 mg liraglutide ...
An interrupted time-series analysis of nearly 10,000 medicine presentations shows that Argentina's December 2023 economic shock left minimum-pension retirees facing ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine